Related Experiment Video
Updated: May 16, 2026
09:26
Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication
Published on: February 6, 2019
Dose-related effects of alcohol on cognitive functioning.
Matthew J Dry1, Nicholas R Burns, Ted Nettelbeck
1School of Psychology, University of Adelaide, Adelaide, South Australia, Australia. matthew.dry@adelaide.edu.au
Plos One
|December 5, 2012
Summary
This study evaluated cognitive tests for alcohol intoxication. The Inspection Time (IT) test effectively measured dose-related alcohol impairment, showing reliable declines with rising blood alcohol concentration (BAC).
Area of Science:
- Neuroscience
- Cognitive Psychology
- Forensic Science
Background:
- Alcohol intoxication significantly impairs cognitive functions.
- Previous research has not comprehensively compared alcohol's effects across diverse cognitive domains.
- Identifying a reliable marker for alcohol's cognitive impact is crucial.
Purpose of the Study:
- To assess six applied cognitive tests for their suitability as a single marker of alcohol intoxication.
- To determine which cognitive test best reflects dose-dependent alcohol effects.
- To investigate the differential impact of alcohol on various cognitive processes.
Main Methods:
- Adult participants (N=56) were exposed to controlled alcohol dosages (BACs 0.00-0.10%).
- A battery of six psychometric tests was administered: UFOV, SOPT, IT, TSP, SART, and TMT.
- A mixed-design experiment with repeated measures was employed.
Main Results:
- Cognitive impairment from alcohol was not uniform across all tested domains.
- The magnitude of alcohol's effect and its dose-response relationship varied significantly between cognitive processes.
- The Inspection Time (IT) test demonstrated a reliable, dose-related decline in processing speed with increasing BAC levels.
Conclusions:
- The Inspection Time (IT) test is a suitable marker for dose-related alcohol intoxication due to its sensitivity and non-invasive nature.
- Cognitive flexibility, working memory, and vigilance are differentially affected by alcohol.
- Future research should focus on IT as a standardized measure for alcohol's cognitive impact.
Related Concept Videos
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...